A Free FDAnews Webinar, Sponsored by Instem
April 20th – Please read our latest update on how we’re helping clients fight the COVID-19 pandemic.
Instem’s submit™-SEND tools and services are the most widely adopted
in the industry, operating at over 80 sites across 15 countries
Instem Technology Selected to Streamline Preclinical Operations, Improve Productivity and Ensure SEND Compliance at South Korea’s Largest Preclinical R&D Facility
Instem Continues to Ramp up as Demand for Target Safety Assessment Service Reaches New Heights
Provantis Selected to Improve Study Turnaround Times and Further Increase Data Quality at Pune Facility
To help you evaluate systems, we believe that an initial, no-pressure demonstration carried out over the Internet is the way to go.
© 2020 Instem Group of Companies